CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Sonoma Pharmaceuticals Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Sonoma Pharmaceuticals Inc
5445 CONESTOGA COURT, SUITE 150
Phone: (617) 243-0050p:617 243-0050 BOULDER, CO  80301  United States Ticker: SNOASNOA
Business Summary
Sonoma Pharmaceuticals, Inc. is a global healthcare company, which is engaged in developing and producing stabilized hypochlorous acid (HOCl), products for a range of applications, including wound care, eye care, oral care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants. The Company's product offerings include Lumacyn Clarifying Mist; Regenacyn Advanced Scar Gel; Reliefacyn Advanced Itch-Burn-Rash-Pain Relief Hydrogel; Microcyn OTC Advanced Wound & Skin Cleanser; Podiacyn Advanced Everyday Foot Care, MicrocynAH and others. Lumacyn Clarifying Mist is intended for use as a daily skin toner, to soothe and cleanse the skin, reduce redness, and manage blemishes by reducing infection. Podiacyn is intended for management of foot odors, infections, and irritations, as well as daily foot health and hygiene. MicrocynAH is an HOCl-based topical product that cleans, debrides and treats a range of animal wounds and infections.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/20243/31/2024YesYes--Yes

Industries
SIC Code Description
3841 Surgical and medical instruments and apparatus
2834 Pharmaceutical preparations
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Executive Officer, Director AmyTrombly 57 7/22/2022 9/27/2019
Chief Financial Officer JerryDvonch 56 2/7/2024 9/8/2020
Chief Operating Officer, Executive Vice President, Corporate Secretary BruceThornton 59 4/1/2023 6/1/2005
3 additional Officers and Directors records available in full report.

Business Names
Business Name
Aquamed Technologies, Inc.
OCLS
Oculus Technologies of Mexico, S.A. de C.V.
SNOA
Sonoma Pharmaceuticals Netherlands B.V.

General Information
Number of Employees: 172 (As of 6/17/2024)
Outstanding Shares: 1,338,615 (As of 9/18/2024)
Shareholders: 291
Stock Exchange: NASD
Federal Tax Id: 680423298
Fax Number: (707) 283-0551


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, October 30, 2024